Fundraising Fox
Lisenid
4 employees on LinkedIn · 1 known investors
Find your way into Lisenid
Sign up to see every warm intro you have to Lisenid
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lisenid team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LisenID develops a molecular diagnostics test and platform that uses Loss of Imprinting (LOI) epigenetic biomarkers combined with AI to detect and predict cancer from routine tumor biopsy samples across multiple cancer types. It targets clinicians and patients facing ambiguous biopsy results, working in the cancer diagnostics field.
Founders & leadership
DN
Dr. Ning ZhouCo-Founder and Chairman
DT
Dr. Tina ChengCo-Founder and CTO
HZ
Hannah ZhouPartner & CEOHannah Zhou has nearly a decade of experience in health systems, consulting, SaaS, and early-stage biotech, including roles in organizational strategy, product development, and sales. She is Partner and CEO of LisenID, which develops molecular diagnostics tests using epigenetic biomarkers and AI to detect cancer from biopsy samples.
Investors · 1
Related companies · 2
Function HealthFunction Health provides routine whole-body lab testing, advanced imaging, and access to top doctors to help individuals achieve preventive health awareness and disease avoidance. The company combines medical diagnostics with technology to give patients comprehensive health insights.
CepheidCepheid manufactures molecular diagnostic instruments and tests that automate PCR-based testing for infectious diseases, oncology, and human genetics. The company serves institutions ranging from central laboratories to near-patient settings with automated diagnostic solutions.
Companies working in the same space as Lisenid.
Frequently asked questions
- What does Lisenid do?
- LisenID develops a molecular diagnostics test and platform that uses Loss of Imprinting (LOI) epigenetic biomarkers combined with AI to detect and predict cancer from routine tumor biopsy samples across multiple cancer types. It targets clinicians and patients facing ambiguous biopsy results, working in the cancer diagnostics field.
- Who founded Lisenid?
- Lisenid was founded by Dr. Ning Zhou, Dr. Tina Cheng.
- Who are Lisenid's investors?
- Lisenid's investors include The Innovation Space.